Thursday, September 10, 2026

TOPICS

Home Tags Rubius Therapeutics

Tag: Rubius Therapeutics

Rubius announces 3 new patents for cellular-therapy program

PROVIDENCE – Rubius Therapeutics, a Cambridge, Mass.-based biotech firm that develops and genetically engineers red blood cells for use in medications for rare diseases,...
RUBIUS THERAPEUTICS reported a $32.6 million loss in the first quarter of 2019.

Rubius Therapeutics reports $32.6M loss in Q1

SMITHFIELD – Rubius Therapeutics Inc. reported a net loss of $32.6 million in the first quarter of 2019, or 42 cents per diluted share,...

Rubius appoints Holles to board, Whitehead as SVP, chief quality officer

PROVIDENCE – Rubius Therapeutics Inc. has appointed Natalie Holles to its board of directors and Greg Whitehead as senior vice president and chief quality...

Rubius Therapeutics added to Nasdaq biotechnology index

SMITHFIELD – Biotechnology firm Rubius Therapeutics Inc. was added to the Nasdaq biotechnology index on Dec. 24. The company, based in Cambridge, Mass., but building...
RUBIUS THERAPEUTICS reported a $26.4 million loss for the third quarter. The company does not yet generate revenue.

Rubius reports $26.4M loss for Q3

PROVIDENCE – Cambridge, Mass.-headquartered Rubius Therapeutics Inc. announced a $26.4 million net loss for the third quarter of 2018 Tuesday. The company reported an...
PBN PHOTO/MIKE SKORSKI

Most-read stories on PBN.com, July 2018

1. 2018 40 Under Forty winners feted at Aldrich Mansion POSTED ONLINE: JULY 20. A record crowd of 475 took the occasion of a...

Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield

SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to...

Rebuild Rhode Island tax credit program surpasses $100M mark

PROVIDENCE – The state’s Rebuild Rhode Island tax credit program recently exceeded the $100 million mark with last month’s award to Rubius Therapeutics Inc. The...

BBJ: Rubius Therapeutics raises $241M in IPO, highest for biotech company...

PROVIDENCE – Cambridge, Mass.-based Rubius Therapeutics Inc. raised $241 million in its initial public offering Wednesday, the highest for a biotechnology company in Massachusetts...

Most read stories on PBN.com, June 2018

1. 2018 40 under Forty winners chosen POSTED ONLINE: JUNE 8. Providence Business News has chosen the winners for its 14th 40 Under Forty program,...
- Featured Event -

Latest News